跳至主要内容
临床试验/CTRI/2024/11/076912
CTRI/2024/11/076912尚未招募2/3 期

EECP (Enhanced External Counter Pulsation) & HBOT (Hyper Baric Oxygen Therapy) as an adjuvant therapy in ischemic cardiomyopathy.

Oxymed Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年11月29日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
MACE

研究概览

简要总结

100 patients with refractory ischemic heart failure with reduced ejection fraction will be included in this study by invitation.

A prospective cohort study design will be employed and patient volunteers will be followed up over a period of 2 years. The volunteers after fulfilling the inclusion exclusion criteria will be subjected to baseline investigations involving 6 MWD, MLHFS, NT pro BNP,  LVEF by Simpson’s biplane method and GLS using 2 dimensional echocardiography.

Patients will be subjected to daily sessions of Hyperbaric oxygen therapy ( 20 x 90 minute sessions ) followed by 40 EECP sessions ( 1 hour each ) over a period of 6 weeks. They will be assessed at the end of therapy with same investigations at baseline. Follow up will continue at frequent intervals at 6 months , 1 year and 2 years.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Ischemic HFrEF( ejection fraction less than 50%) with NYHA Class 2 or more symptoms despite optimal GDMT.
  • Post revascularization on GDMT with worsening heart failure symptoms.
  • Coronary anatomy not suitable for repeat revascularization.

排除标准

  • Recent acute coronary syndrome (within 1 month).
  • Recent PTCA ( less than 2 weeks) or CABG (within 3 months).
  • Severe peripheral arterial disease, greater than Moderate Aortic regurgitation or stenosis, HOCM, severe Mitral regurgitation, DVT , Arterial aneurysms, AFib with FVR , bleeding disorders, and uncontrolled hypertension.
  • Volume overloaded pts.

结局指标

主要结局

MACE

时间窗: 6 months | 1 year | 2 year

First hospitalization due to heart failure

时间窗: 6 months | 1 year | 2 year

次要结局

  • All cause mortality.(Change from baseline in the clinical summary on the Minnesota living with heart failure score(MLFHS).)

研究者

发起方
Oxymed Hospital
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Dr Sama Akber DNB DM

Oxymed Hospital

研究点 (1)

Loading locations...

相似试验